{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:39:53Z","timestamp":1791999593195,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"The State Key Laboratory Base of Xinjiang Major Disease Research","award":["2010DS 890294"],"award-info":[{"award-number":["2010DS 890294"]}]},{"name":"Key Discipline Construction Fund of Xinjiang, Urumqi, China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-016-2152-4","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T08:18:19Z","timestamp":1483604299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["High prevalence and low cure rate of tuberculosis among patients with HIV in Xinjiang, China"],"prefix":"10.1186","volume":"17","author":[{"given":"Rena","family":"Maimaiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peierdun","family":"Mijiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimaitiali","family":"Wubili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimaitijiang","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,5]]},"reference":[{"key":"2152_CR1","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1086\/651500","volume":"50","author":"M Harrington","year":"2010","unstructured":"Harrington M. From HIV, to tuberculosis and back again: a tale of activism in 2 pandemics. Clin Infect Dis. 2010;50:S260\u20136.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"2152_CR2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/518667","volume":"196","author":"G Friedland","year":"2007","unstructured":"Friedland G, Churchyard GJ, Nardell E. Tuberculosis and HIV coinfection: current state of knowledge and research priorities. J Infect Dis. 2007;196 Suppl 1:S1\u20133.","journal-title":"J Infect Dis"},{"key":"2152_CR3","unstructured":"WHO TB Report 2014. http:\/\/apps.who.int\/iris\/bitstream\/10665\/137094\/1\/9789241564809_eng.pdf . Accessed 28 Dec 2016."},{"key":"2152_CR4","unstructured":"Global tuberculosis control. WHO report 2013, WHO\/HTM\/TB\/2013.11. http:\/\/apps.who.int\/iris\/bitstream\/10665\/91355\/1\/9789241564656_eng.pdf . Accessed 10 Apr 2015."},{"issue":"10","key":"2152_CR5","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/aje\/kwk116","volume":"165","author":"H L\u00f3pez-Gatell","year":"2007","unstructured":"L\u00f3pez-Gatell H, Cole SR, Hessol NA, French AL, Greenblatt RM, Landesman S, et al. Effect of tuberculosis on the survival of women infected with human immunodeficiency virus. Am J Epidemiol. 2007;165(10):1134\u201342.","journal-title":"Am J Epidemiol"},{"key":"2152_CR6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2796.2007.01795.x","volume":"261","author":"DB Meya","year":"2007","unstructured":"Meya DB, McAdam KP. The TB pandemic: an old problem seeking new solutions. J Intern Med. 2007;261:309\u201329.","journal-title":"J Intern Med"},{"issue":"Suppl 3","key":"2152_CR7","first-page":"S47","volume":"14","author":"E Girardi","year":"2000","unstructured":"Girardi E, Raviglione MC, Antonucci G, Godfrey-Faussett P, Ippolito G. Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. AIDS. 2000;14 Suppl 3:S47\u201356.","journal-title":"AIDS"},{"key":"2152_CR8","volume-title":"Global tuberculosis control 2009: epidemiology, strategy, financinf","author":"WHO","year":"2009","unstructured":"WHO. Global tuberculosis control 2009: epidemiology, strategy, financinf. Geneva: World Health Organization; 2009. http:\/\/apps.who.int\/bookorders\/anglais\/detart1.jsp?codlan=1&codcol=15&codcch=4659 . Accessed 28 Dec 2016."},{"issue":"7","key":"2152_CR9","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1086\/651081","volume":"50","author":"KP Reddy","year":"2010","unstructured":"Reddy KP, Brady MF, Gilman RH, et al. Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons. Clin Infect Dis. 2010;50(7):988\u201396. doi: 10.1086\/651081 .","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2152_CR10","first-page":"927","volume":"13","author":"N A\u00eft-Khaled","year":"2009","unstructured":"A\u00eft-Khaled N, Alarcon E, Bissell K, et al. Isoniazid preventive therapy for people living with HIV : public health challenges and implementation issues. Int J Tuberc Lung Dis. 2009;13(8):927\u201335.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2152_CR11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s15010-002-2062-9","volume":"30","author":"F Palmieri","year":"2002","unstructured":"Palmieri F, Girardi E, Pellicelli AM, et al. Pulmonary tuberculosis in HIV-infected patients presenting with normal chest radiograph and negative sputum smear. Infection. 2002;30:68\u201374.","journal-title":"Infection"},{"issue":"3","key":"2152_CR12","first-page":"44","volume":"25","author":"X Yuan","year":"2010","unstructured":"Yuan X. The impact of the implementation of the DOTS strategy to TB control in Shihezi region. Endem Dis Bull. 2010;25(3):44\u20135.","journal-title":"Endem Dis Bull"},{"issue":"2","key":"2152_CR13","doi-asserted-by":"publisher","first-page":"e32103","DOI":"10.1371\/journal.pone.0032103","volume":"7","author":"Y-C Qi","year":"2012","unstructured":"Qi Y-C, Ma M-J, Li D-J, Chen M-J, Lu Q-B, Li X-J, et al. Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic Region, Xinjiang Uygur Autonomous Region, China. PLoS ONE. 2012;7(2):e32103. doi: 10.1371\/journal.pone.0032103 .","journal-title":"PLoS ONE"},{"issue":"11","key":"2152_CR14","first-page":"767","volume":"32","author":"L Yuehua","year":"2010","unstructured":"Yuehua L, Wu G, Mahemuti M. Evaluation of Xinjiang fifth round of global fund tuberculosis and AIDS co-infection control project. China tuberculosis control collaboration. Lancet. 2010;32(11):767\u20139.","journal-title":"Lancet"},{"issue":"3","key":"2152_CR15","first-page":"19","volume":"29","author":"L Yuehua","year":"2014","unstructured":"Yuehua L, Wang X, Xue F, et al. Current status of HIV infection in patients with tuberculosis in Xinjiang. Dis Prev Control Bull. 2014;29(3):19\u201321.","journal-title":"Dis Prev Control Bull"},{"issue":"8","key":"2152_CR16","first-page":"1101","volume":"29","author":"NI Mingjian","year":"2013","unstructured":"Mingjian NI, Xueling CHEN, Jin CHEN, Wen HE, Wei LIU. HIV infection prevalence factors among drug users in Xinjiang. China J Public Health. 2013;29(8):1101\u20133.","journal-title":"China J Public Health"},{"issue":"1","key":"2152_CR17","first-page":"70","volume":"24","author":"Chinese society of tuberculosis, Chinese Medical Association","year":"2001","unstructured":"Chinese society of tuberculosis, Chinese Medical Association. Tuberculosis diagnosis and treatment guidelines. Chinese J Tuberc Respir Dis. 2001;24(1):70\u20134.","journal-title":"Chinese J Tuberc Respir Dis"},{"key":"2152_CR18","volume-title":"Implementing the WHO stop TB strategy: a handbook for national tuberculosis control programmes","author":"A Piot","year":"2008","unstructured":"Piot A, Chaulet P. Implementing the WHO stop TB strategy: a handbook for national tuberculosis control programmes. Geneva: World Health Organization; 2008."},{"key":"2152_CR19","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/323784","volume":"33","author":"CR Driver","year":"2001","unstructured":"Driver CR, Munsiff SS, Li J, Kundamal N, Osahan SS. Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City. Clin Infect Dis. 2001;33:1762\u20139.","journal-title":"Clin Infect Dis"},{"key":"2152_CR20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/00365548.2010.495725","volume":"42","author":"PJ Munseri","year":"2010","unstructured":"Munseri PJ, Bakari M, Pallangyo K, Sandstrom E. Tuberculosis in HIV voluntary counselling and testing centres in Dar es Salaam, Tanzania. Scand J Infect Dis. 2010;42:767\u201374.","journal-title":"Scand J Infect Dis"},{"key":"2152_CR21","unstructured":"2012 China AIDS Response Progress Report, Ministry of Health of the People\u2019s Republic of China 31 March 2012. http:\/\/www.unaids.org\/sites\/default\/files\/country\/documents\/\/file,68497,ru..pdf . Accessed 28 Dec 2016."},{"key":"2152_CR22","unstructured":"World Health Organisation: Global tuberculosis control. WHO report; 2011. http:\/\/apps.who.int\/iris\/bitstream\/10665\/44728\/1\/9789241564380_eng.pdf . Accessed 28 Dec 2016."},{"issue":"6","key":"2152_CR23","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/tmi.12308","volume":"19","author":"TT Balcha","year":"2014","unstructured":"Balcha TT, Winqvist N, Stureg\u00e5rd E, Skogmar S, Reepalu A, Jemal ZH, et al. Detection of lipoarabinomannan in urine for identification of active tuberculosis among HIV-positive adults in Ethiopian health centres. Trop Med Int Health. 2014;19(6):734\u201342.","journal-title":"Trop Med Int Health"},{"key":"2152_CR24","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/605559","volume":"49","author":"HM Peto","year":"2009","unstructured":"Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993\u20132006. Clin Infect Dis. 2009;49:1350\u20137.","journal-title":"Clin Infect Dis"},{"key":"2152_CR25","unstructured":"Bureau of Health XUAR World TB Day. Bulletin.2011.3.23. http:\/\/www.xjwst.gov.cn . Accessed 10 Nov 2013."},{"key":"2152_CR26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-2458-12-124","volume":"12","author":"KC Takarinda","year":"2012","unstructured":"Takarinda KC, Harries AD, Srinath S, Mutasa-Apollo T, Charles S, Mugurungi O. Treatment outcome of adult patients with recurrent tuberculosis in relation to HIV status in Zimbabwe: a retrospective record review. BMC Public Health. 2012;12:124.","journal-title":"BMC Public Health"},{"key":"2152_CR27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s15010-008-7199-8","volume":"36","author":"CS Wang","year":"2008","unstructured":"Wang CS, Chen HC, Yang CJ, Wang WY, Chong IW, Hwang JJ, et al. The impact of age on the demographic, clinical, radiographic characteristics and treatment outcomes of pulmonary tuberculosis patients in Taiwan. Infection. 2008;36:335\u201340.","journal-title":"Infection"},{"issue":"1","key":"2152_CR28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/cid\/cis303","volume":"55","author":"IL Leeds","year":"2012","unstructured":"Leeds IL, Magee MJ, Kurbatova EV, del Rio C, Blumberg HM, Leonard MK, et al. Site of extrapulmonary tuberculosis is associated with HIV infection. CID. 2012;55(1):75\u201381.","journal-title":"CID"},{"key":"2152_CR29","unstructured":"World Health Organization Global tuberculosis report 2014. World Health Organization, WHO\/HTM\/TB\/2014.08. http:\/\/reliefweb.int\/report\/world\/global-tuberculosis-report-2014 . Accessed 28 Dec 2016."},{"key":"2152_CR30","doi-asserted-by":"publisher","first-page":"e20343","DOI":"10.1371\/journal.pone.0020343","volume":"6","author":"Y Yang","year":"2011","unstructured":"Yang Y, Li X, Zhou F, Jin Q, Gao L. Prevalence of drug-resistant tuberculosis in mainland China: systematic review and meta-analysis. PLoS One. 2011;6:e20343. doi: 10.1371\/journal.pone.0020343 .","journal-title":"PLoS One"},{"key":"2152_CR31","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.meegid.2011.09.022","volume":"12","author":"Z Yuding","year":"2012","unstructured":"Yuding Z, Qin F, Ke T, Congcong Z, Honghu S, Tao L, et al. The population structure of drug-resistant mycobacterium tuberculosis clinical isolates from Sichuan in China. Infect Genet Evol. 2012;12:718\u201324.","journal-title":"Infect Genet Evol"},{"key":"2152_CR32","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(09)60331-7","volume":"373","author":"A Wright","year":"2009","unstructured":"Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, et al. Epidemiology of anti-tuberculosis drug resistance 2002\u201307: an updated analysis of the global project on anti-tuberculosis drug resistance surveillance. Lancet. 2009;373:1861\u201373.","journal-title":"Lancet"},{"key":"2152_CR33","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","volume":"363","author":"CC Boehme","year":"2010","unstructured":"Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363:1005\u201315.","journal-title":"N Engl J Med"},{"key":"2152_CR34","doi-asserted-by":"crossref","unstructured":"Taye T. Balcha, Erik Stureg\u00e5rd, Niclas Winqvist, Sten Skogmar, Anton Reepalu, Zelalem Habtamu Jemal, et al. Intensified Tuberculosis Case-Finding in HIV-Positive Adults Managed at Ethiopian Health Centers: Diagnostic Yield of Xpert MTB\/RIF Compared with Smear Microscopy and Liquid Culture. PLoS ONE. 2014; 9(1): e85478. doi:10.1371. journal.pone.0085478","DOI":"10.1371\/journal.pone.0085478"},{"key":"2152_CR35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(09)70041-6","volume":"9","author":"EW Orenstein","year":"2009","unstructured":"Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis. 2009;9:153\u201361.","journal-title":"Lancet Infect Dis"},{"key":"2152_CR36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1183\/09031936.05.00103504","volume":"26","author":"A Faustini","year":"2005","unstructured":"Faustini A, Hall AJ, Perucci CA. Tuberculosis treatment outcomes in Europe: a systematic review. Eur Respir J. 2005;26:503\u201310.","journal-title":"Eur Respir J"},{"key":"2152_CR37","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1086\/588292","volume":"46","author":"MF Franke","year":"2008","unstructured":"Franke MF, Appleton SC, Bayona J, Arteaga F, Palacios E, Llaro K, et al. Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment. Clin Infect Dis. 2008;46:1844\u201351.","journal-title":"Clin Infect Dis"},{"key":"2152_CR38","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1378\/chest.111.5.1162","volume":"111","author":"AL Kritski","year":"1997","unstructured":"Kritski AL, de Jesus LS R, Andrade MK, Werneck-Barroso E, Vieira MA, Haffner A, et al. Retreatment tuberculosis cases factors associated with drug resistance and adverse outcomes. Chest. 1997;111:1162\u20137.","journal-title":"Chest"},{"issue":"1","key":"2152_CR39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/1545109712446176","volume":"12","author":"R Maimaiti","year":"2013","unstructured":"Maimaiti R, Zhang Y, Pan K, Maimaiti W, Andersson R. Frequent coinfection with hepatitis among HIV-positive patients in Urumqi, China. J Int Assoc Phys AIDS Care (JIAPAC). 2013;12(1):58\u201361.","journal-title":"J Int Assoc Phys AIDS Care (JIAPAC)"},{"key":"2152_CR40","unstructured":"Yang X, Yuan Y, Pang Y, Wang B, Bai Y, Wang Y, et al. The Burden of MDR\/XDR Tuberculosis in Coastal Plains Population of China. PLoS ONE. 2015; 10(2): e0117361. doi:10.1371\/journal. pone.0117361."},{"key":"2152_CR41","unstructured":"The Ministry of Health in China.2011. Bulletin. www.scio.gov.cn . Accessed 22 Mar 2013."},{"key":"2152_CR42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"JD Lundgren","year":"2015","unstructured":"Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, An-chalee A, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373:795\u2013807. doi: 10.1056\/NEJMoa1506816 .","journal-title":"N Engl J Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-2152-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T01:22:34Z","timestamp":1568683354000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-2152-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,5]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2152"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-2152-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,5]]},"article-number":"15"}}